CLL cell-derived exosomes alter the immune and hematopoietic systems

Area of Science:

• Immunology
• Hematology
• Molecular Biology

Background:

• The origins of immunosuppression, neutropenia, and anemia in chronic lymphocytic leukemia (CLL) remain unclear.
• Circulating exosomes, derived from CLL cells, mediate cell-to-cell interactions and may contribute to disease pathology.

Purpose of the Study:

• To investigate whether CLL cell-derived exosomes contribute to the abnormal features observed in CLL patients.
• To determine the impact of CLL exosomes on healthy donor immune and hematopoietic cells.

Main Methods:

• Exosomes isolated from CLL patient cells were co-cultured with healthy donor monocytes, fibrocytes, and lymphocytes.
• Gene and protein expression analysis (including RNA sequencing and qRT-PCR) was performed on target cells.
• Hematopoiesis and immune cell function assays were conducted.

Main Results:

• CLL exosomes altered gene and protein expression in monocytes, lymphocytes, and B cells.
• Exosomes suppressed normal hematopoiesis and inhibited hematopoietic progenitor proliferation.
• Upregulation of immune checkpoints (PD-1, CD160) on T cells and apoptosis induction in B cells were observed.

Conclusions:

• CLL cell-derived exosomes disrupt immune cell function and hematopoiesis, contributing to immunosuppression and anemia in CLL.
• Exosomes carry RNAs that promote apoptosis, increase metabolism, and activate the PI3K-mTOR pathway.
• These findings suggest CLL exosomes play a significant role in disease progression.